Long-acting bronchodilators in patients with chronic obstructive pulmonary disease: still more to know.
作者信息
Shah Tina, Jagpal Sugeet, Beckford Rosemarie
机构信息
1 University of Chicago Chicago, Illinois.
出版信息
Ann Am Thorac Soc. 2014 Nov;11(9):1504. doi: 10.1513/AnnalsATS.201409-439LE.
Abstract
摘要
相似文献
1
Long-acting bronchodilators in patients with chronic obstructive pulmonary disease: still more to know.慢性阻塞性肺疾病患者使用长效支气管扩张剂：仍有更多需要了解的地方。
Ann Am Thorac Soc. 2014 Nov;11(9):1504. doi: 10.1513/AnnalsATS.201409-439LE.
2
Reply: long-acting bronchodilators in patients with chronic obstructive pulmonary disease: still more to know.回复：慢性阻塞性肺疾病患者使用长效支气管扩张剂：仍有更多有待了解之处。
Ann Am Thorac Soc. 2014 Nov;11(9):1505. doi: 10.1513/AnnalsATS.201410-451LE.
3
Long-acting bronchodilators in COPD.
Chest. 2008 May;133(5):1057-8. doi: 10.1378/chest.07-2919.
4
[Bronchodilators in the treatment for chronic obstructive pulmonary disease].[支气管扩张剂在慢性阻塞性肺疾病治疗中的应用]
Recenti Prog Med. 2005 Mar;96(3):148-50.
5
Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?哪种支气管扩张剂治疗慢性阻塞性肺疾病最佳？
Expert Rev Respir Med. 2013 Apr;7(2 Suppl):17-24. doi: 10.1586/ers.13.18.
6
Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.慢性阻塞性肺疾病中的心脏选择性和非选择性β受体阻滞剂：对支气管扩张剂反应和运动的影响。
Intern Med J. 2010 Mar;40(3):193-200. doi: 10.1111/j.1445-5994.2009.01943.x. Epub 2009 Mar 10.
7
[Tiotropium: new about known].噻托溴铵：旧药新说
Ter Arkh. 2008;80(3):82-4.
8
[New cholinergic drugs in asthma and COPD].[哮喘和慢性阻塞性肺疾病中的新型胆碱能药物]
Pneumonol Alergol Pol. 2002;70 Suppl 1:61-3.
9
Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler.哮喘和慢性阻塞性肺疾病（COPD）患者长期使用Respimat软雾吸入器期间矛盾性支气管收缩的发生率较低。
Respir Med. 2005 Sep;99(9):1087-95. doi: 10.1016/j.rmed.2005.03.037.
10
Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者停用吸入长效支气管扩张剂治疗的发生率、预测因素及临床意义
COPD. 2016 Oct;13(5):540-6. doi: 10.3109/15412555.2016.1141877. Epub 2016 Mar 2.
本文引用的文献
1
Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease.慢性阻塞性肺疾病住院患者使用长效支气管扩张剂的情况及相关结局
Ann Am Thorac Soc. 2014 Oct;11(8):1186-94. doi: 10.1513/AnnalsATS.201407-311OC.
2
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.全球慢性阻塞性肺疾病诊断、管理和预防策略：GOLD 执行摘要。
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.
3
Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial.教授哮喘或 COPD 住院患者使用呼吸吸入器：一项随机试验。
J Gen Intern Med. 2012 Oct;27(10):1317-25. doi: 10.1007/s11606-012-2090-9. Epub 2012 May 17.
4
The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.国际疾病分类，第九版，临床修订本诊断代码用于识别因 COPD 加重而住院的患者的有效性。
Chest. 2012 Jan;141(1):87-93. doi: 10.1378/chest.11-0024. Epub 2011 Jul 14.
5
Diagnosis of COPD in hospitalised patients.住院患者的 COPD 诊断。
Arch Bronconeumol. 2010 Feb;46(2):64-9. doi: 10.1016/j.arbres.2009.10.012. Epub 2009 Dec 8.
6
Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重和呼吸衰竭
Proc Am Thorac Soc. 2008 May 1;5(4):530-5. doi: 10.1513/pats.200707-088ET.
Zotero 插件